Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Preprints

Date Submitted: Aug 2, 2020

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Review: Toxicology testing of new medicines for children

  • Dardan Dreshaj; 
  • Flaka Pasha

ABSTRACT

Abstract -Objectives This review represents a critical and constructive analysis of literature in the content of toxicology testing of new medicines for children. The review is generated through summary, classification, analysis and comparison of already existing material and researches on field. -Materials and methods Databases as Scopus, PubMed, Medline and Web of Science were used to extract data for the review. Search terms like “juvenile toxicity studies”, “children toxicology”, “testing of new drugs” were used. Out of 150 research articles screened, 25 most relevant studies are included in this review. -Results Whether juvenile animal toxicology studies are truly useful or necessary to support pediatric drug development is still doubtful. The current knowledge on cross-species functional and kinetic differences is not reliable, meaning that extrapolation of any toxicology study finding to an immature human may not be relevant, especially if performed at the wrong time and in the wrong species. -Conclusion Even though, great improvements and regulatory initiatives regarding juvenile toxicity studies have been accomplished, unfortunately testing new drugs in children still remains on its initial stage and lags behind to other scientific developments. In order to narrow down the juvenile toxicity studies loophole, we need to improve compliance by drug companies and research sponsors with pediatric trial obligations.


 Citation

Please cite as:

Dreshaj D, Pasha F

Review: Toxicology testing of new medicines for children

JMIR Preprints. 02/08/2020:23140

DOI: 10.2196/preprints.23140

URL: https://preprints.jmir.org/preprint/23140

PDF not available

The author of this paper has made a PDF available, but requires the user to login, or create an account.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.